The Clinical and Translational Science Award (CTSA) Program offers the Collaborative and Innovative Acceleration Award (CCIA) to significantly accelerate the translational research process. This grant supports synergistic activities focused on developing, demonstrating, and disseminating innovative solutions. The primary aim is to transform translational science by efficiently addressing common inefficiencies across various diseases. The initiative seeks to expedite the delivery of interventions to all people more rapidly. Applications are encouraged for collaborative science involving CTSA Program hubs, NIH Institutes, Centers, and Offices, as well as other external stakeholders, fostering a broad and impactful approach to advancing health solutions.
Opportunity ID: 340192
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-167 |
| Funding Opportunity Title: | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 09, 2022 |
| Last Updated Date: | May 09, 2022 |
| Original Closing Date for Applications: | Oct 17, 2024 |
| Current Closing Date for Applications: | Oct 17, 2024 |
| Archive Date: | Nov 22, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs) and/or external stakeholders. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-167.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00274093 | Jun 15, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278448 | Nov 15, 2022 | Oct 17, 2024 | View |
Package 1
Mandatory forms
340192 RR_SF424_5_0-5.0.pdf
340192 PHS398_CoverPageSupplement_5_0-5.0.pdf
340192 RR_OtherProjectInfo_1_4-1.4.pdf
340192 PerformanceSite_4_0-4.0.pdf
340192 RR_KeyPersonExpanded_4_0-4.0.pdf
340192 RR_Budget_3_0-3.0.pdf
340192 PHS398_ResearchPlan_4_0-4.0.pdf
340192 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
340192 RR_SubawardBudget30_3_0-3.0.pdf
340192 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
340192 RR_SF424_5_0-5.0.pdf
340192 PHS398_CoverPageSupplement_5_0-5.0.pdf
340192 RR_OtherProjectInfo_1_4-1.4.pdf
340192 PerformanceSite_4_0-4.0.pdf
340192 RR_KeyPersonExpanded_4_0-4.0.pdf
340192 RR_Budget_3_0-3.0.pdf
340192 PHS398_ResearchPlan_5_0-5.0.pdf
340192 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
340192 RR_SubawardBudget30_3_0-3.0.pdf
340192 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
